AVAVA, Inc. is a Waltham, Massachusetts medical aesthetics company that builds energy-based laser platforms for skin renewal that work across all skin tones. Spun out of Boston-based Blossom Innovations and rooted in research from Massachusetts General Hospital's Wellman Center for Photomedicine, AVAVA's flagship MIRIA Skin Treatment System pairs patented Focal Point Technology with AI-driven skin visualization to deliver precise, high-energy intradermal treatment for conditions like melasma, hyperpigmentation, and acne scars with minimal downtime.
Irina Erenburg is the founder, president and CEO of AVAVA, a Waltham, Massachusetts medical aesthetics company behind MIRIA, a new class of dermatology laser built on the company's proprietary Focal Point Technology. A biomedical scientist turned serial entrepreneur, she earned a PhD from the Mount Sinai School of Medicine and got her start negotiating high-value deals inside Boston's largest hospital network, where she helped shepherd startups including Zeltiq Aesthetics. She has co-founded R2 Dermatology and Soltego and, in 2024, raised $35 million to commercialize AVAVA's technology for treating skin of every tone.